Are stem-like cells responsible for resistance to therapy in breast cancer?

Breast Dis. 2008:29:83-9. doi: 10.3233/bd-2008-29109.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology*
  • Drug Resistance, Neoplasm*
  • ErbB Receptors / antagonists & inhibitors
  • Female
  • Humans
  • Neoplastic Stem Cells*
  • Radiotherapy / adverse effects
  • Receptor, ErbB-2 / metabolism
  • Receptors, Estradiol / metabolism
  • Receptors, Estrogen / metabolism
  • Receptors, Progesterone / metabolism
  • Treatment Failure

Substances

  • Antineoplastic Agents
  • Receptors, Estradiol
  • Receptors, Estrogen
  • Receptors, Progesterone
  • ErbB Receptors
  • Receptor, ErbB-2